V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210002785 | 210010222 | 1.61 | 59.1 | Adjuvant (A) | 2017-07-02 | 2017-09-26 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 101711722 |
| 210002786 | 210010223 | null | 76 | null | 2019-01-24 | 2019-02-16 | EC | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100132969 |
| 210002789 | 210010225 | 1.85 | 56 | null | null | 2018-05-10 | Docetaxel | 02 | null | DOCETAXEL | 100284199 |
| 210002790 | 210010226 | 1.59 | 95.8 | null | null | 2021-12-05 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 101296586 |
| 210002793 | 210010228 | null | 88.9 | null | 2018-05-09 | 2018-07-20 | Trastuzumab | null | null | TRASTUZUMAB | 101057989 |
| 210002796 | 210010230 | 1.63 | 64.2 | Neo-adjuvant (N) | 2016-12-30 | 2017-01-01 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 100652125 |
| 210002797 | 210010231 | 1.64 | 81.2 | Palliative (P) | 2018-07-03 | 2018-07-23 | Trastuzumab Subcutaneous | 02 | Y | TRASTUZUMAB | 100731070 |
| 210002801 | 210010232 | 1.69 | 83.5 | Adjuvant (A) | null | 2021-01-29 | Docetaxel | 02 | N | DOCETAXEL | 101390908 |
| 210002802 | 210010233 | 1.71 | 73.2 | Neo-adjuvant (N) | 2017-02-24 | 2017-02-26 | PACLITAXEL | 02 | N | PACLITAXEL | 100054339 |
| 210002803 | 210010234 | 1.63 | 78.9 | Adjuvant (A) | 2019-10-15 | 2019-12-18 | Paclitaxel 7 day | N | N | PACLITAXEL | 100331790 |
| 210002804 | 210010235 | 1.61 | 63.1 | Neo-adjuvant (N) | null | 2017-02-23 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 100294758 |
| 210002805 | 210010236 | 1.57 | 55.7 | Palliative (P) | 2020-04-17 | 2020-05-19 | Trastuzumab Subcutaneous | N | N | TRASTUZUMAB | 101615942 |
| 210002806 | 210010237 | 1.5 | 65.4 | Adjuvant (A) | 2018-07-23 | 2018-08-09 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101280102 |
| 210002808 | 210010238 | 1.62 | 78.6 | null | 2018-12-30 | 2018-12-31 | Docetaxel | null | null | DOCETAXEL | 100176034 |
| 210002811 | 210010239 | 1.58 | 95 | Neo-adjuvant (N) | 2019-02-24 | 2019-03-17 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101738903 |
| 210002812 | 210010240 | 1.65 | 76.3 | Adjuvant (A) | 2019-07-31 | 2019-08-21 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101372776 |
| 210002813 | 210010241 | 1.58 | 67.5 | null | 2018-06-26 | 2018-07-01 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | null | PACLITAXEL | 100931928 |
| 210002815 | 210010242 | 1.62 | 76.8 | Palliative (P) | null | 2019-01-24 | Trastuzumab | null | N | TRASTUZUMAB | 100882474 |
| 210002817 | 210010244 | null | 89.8 | null | 2018-10-17 | 2018-10-24 | Trastuzumab | 02 | null | TRASTUZUMAB | 101160914 |
| 210002818 | 210010245 | 1.6 | 72.9 | Adjuvant (A) | null | 2016-07-14 | Docetaxel | 02 | N | DOCETAXEL | 101143154 |
| 210002819 | 210010246 | null | 105 | Not known (9) | 2019-07-25 | 2019-08-15 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 100297554 |
| 210002820 | 210010247 | 1.58 | 81 | Neo-adjuvant (N) | null | 2018-09-10 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100906082 |
| 210002821 | 210010248 | 1.76 | 55.6 | Neo-adjuvant (N) | 2018-07-27 | 2018-08-04 | Paclitaxel 7 day | N | N | PACLITAXEL | 100112323 |
| 210002825 | 210010250 | 1.64 | 82.8 | Curative (C) | 2019-08-26 | 2019-10-05 | Trastuzumab | null | null | TRASTUZUMAB | 101483217 |
| 210002828 | 210010252 | 1.62 | 48.2 | Neo-adjuvant (N) | 2017-06-15 | 2017-07-08 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101782261 |
| 210002830 | 210010254 | 1.88 | 54.6 | Adjuvant (A) | null | 2018-01-23 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 100861905 |
| 210002835 | 210010255 | 1.52 | 88.8 | Palliative (P) | null | 2020-05-12 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100308047 |
| 210002836 | 210010256 | null | 48 | Adjuvant (A) | null | 2017-09-18 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100919568 |
| 210002837 | 210010257 | 1.66 | 56.7 | Adjuvant (A) | 2019-09-15 | 2019-10-05 | Paclitaxel (2 or 3 weekly) | 02 | null | PACLITAXEL | 100468296 |
| 210002838 | 210010258 | 1.58 | null | null | 2017-09-05 | 2017-09-13 | EC | N | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101752604 |
| 210002842 | 210010261 | 1.67 | 65 | Curative (C) | 2017-10-11 | 2019-02-03 | EC | N | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101791004 |
| 210002843 | 210010262 | 1.55 | 85.1 | Palliative (P) | 2020-02-21 | 2020-03-02 | PACLITAXEL | null | N | PACLITAXEL | 101788009 |
| 210002844 | 210010263 | 1.66 | 64.15 | Neo-adjuvant (N) | 2017-01-09 | 2018-03-10 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 101044268 |
| 210002851 | 210010265 | null | 64.3 | null | 2018-08-23 | 2018-08-23 | TRASTUZUMAB | 02 | null | TRASTUZUMAB | 100371474 |
| 210002854 | 210010266 | null | null | Palliative (P) | null | 2017-09-16 | Docetaxel | null | N | DOCETAXEL | 100773920 |
| 210002861 | 210010269 | 1.68 | 98.8 | Adjuvant (A) | 2018-04-28 | 2018-07-01 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101578111 |
| 210002862 | 210010270 | null | 77.8 | null | 2018-11-05 | 2018-12-09 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 101200039 |
| 210002866 | 210010272 | 1.73 | 61.1 | Adjuvant (A) | 2021-02-10 | 2021-04-14 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100546845 |
| 210002867 | 210010273 | 1.71 | 79 | Adjuvant (A) | 2019-04-04 | 2019-04-07 | Docetaxel 100mg/m2 (21 day) | 02 | null | DOCETAXEL | 100232881 |
| 210002871 | 210010275 | 1.61 | 63.5 | Adjuvant (A) | 2019-08-30 | 2019-12-08 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 100917260 |
| 210002872 | 210010276 | null | 92.8 | Adjuvant (A) | null | 2017-01-28 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100224710 |
| 210002876 | 210010278 | null | 66.4 | null | 2019-11-29 | 2019-12-13 | TRASTUZUMAB | 02 | null | TRASTUZUMAB | 100271841 |
| 210002878 | 210010279 | 1.58 | 125 | Palliative (P) | 2017-05-27 | 2017-05-29 | Trastuzumab | null | N | TRASTUZUMAB | 101006110 |
| 210002879 | 210010280 | 1.52 | 51.6 | Adjuvant (A) | 2016-04-29 | 2016-05-21 | Docetaxel | 02 | N | DOCETAXEL | 101763875 |
| 210002881 | 210010281 | 1.57 | 93.9 | Adjuvant (A) | null | 2019-12-12 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100216802 |
| 210002884 | 210010282 | 1.62 | 65.4 | Adjuvant (A) | 2017-06-19 | 2017-07-04 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 100946010 |
| 210002887 | 210010284 | 1.42 | 59.2 | Curative (C) | 2020-10-08 | 2020-11-06 | EC | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101533304 |
| 210002890 | 210010285 | 1.53 | 104.5 | Palliative (P) | 2016-08-13 | 2016-11-12 | TRASTUZUMAB | 02 | null | TRASTUZUMAB | 100921578 |
| 210002891 | 210010286 | 1.62 | 87 | Adjuvant (A) | null | 2017-03-30 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 101792681 |
| 210002893 | 210010287 | 1.62 | 78.3 | Palliative (P) | 2019-01-14 | 2019-03-09 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 100497400 |